QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III tria 期刊论文 2019 作者:  Guo Y;  Ahn M-J;  Chan A;  Wang C-H;  Kang J-H 收藏  |  浏览/下载：39/0  |  提交时间：2020/01/03 Asian  HNSCC  afatinib  methotrexate   High tRNA Transferase NSUN2 Gene Expression is Associated with Poor Prognosis in Head and Neck Squamous Carcinoma 期刊论文 2018, 卷号: 36, 期号: 4, 页码: 246-253 作者:  Lu, Lingeng;  Zhu, Gongjian;  Zeng, Hongmei;  Xu, Qian;  Holzmann, Klaus 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 HNSCC  NUSN2  prognosis  RNA modification-associated gene   Phase III study of afatinib vs methotrexate (MTX) for second-line recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients after platinum-based chemotherapy (CT) in Asia/Middle East/North Africa: LUX-Head & Neck 3 会议论文 ANNALS OF ONCOLOGY, 2015-12-01 作者:  Tang, P. Z.;  Ahn, M.J.;  Zhang, Q.;  Chan, A.;  Kim, S.B. 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04 Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4) 会议论文 ANNALS OF ONCOLOGY, 2015-12-01 作者:  Hu, C. S.;  Chan, A.;  Gao, L.;  Ahn, M.J.;  Cohen, E. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4) 期刊论文 2015, 卷号: 26, 页码: 100-100 作者:  Hu, C. S.;  Chan, A.;  Gao, L.;  Ahn, M.J.;  Cohen, E. 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/13 Phase III study of afatinib vs methotrexate (MTX) for second-line recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients after platinum-based chemotherapy (CT) in Asia/Middle East/North Africa: LUX-Head & Neck 3 期刊论文 2015, 卷号: 26, 页码: 100-100 作者:  Tang, P. Z.;  Ahn, M.J.;  Zhang, Q.;  Chan, A.;  Kim, S.B. 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/13